Arrowhead Pharmaceuticals (ARWR) Change in Receivables (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) recorded Change in Receivables of -$6.95 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $7.48 million a year earlier.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Change in Receivables (2011 - 2026) Analysis & Trends
On a TTM basis, Arrowhead Pharmaceuticals' Change in Receivables came in at $49.03 million as of Jun 30, 2026, up 398.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $56.97 million.
- Annual Change in Receivables has a five-year compound annual growth rate of 214.9% (FY2020 to FY2025).
- Across earlier fiscal years, Change in Receivables came in at -$1.41 million in FY2023, -$8.85 million in FY2022 and $9.41 million in FY2021.
- Quarterly Change in Receivables has ranged from -$203.19 million in fiscal Q2 2026 to $212.05 million in fiscal Q1 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$203.19 million (Q2 2026), $212.05 million (Q1 2026) and $47.13 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | -6.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.95 Mn |
| Mar 31, 2026 | -203.19 Mn |
| Dec 31, 2025 | 212.05 Mn |
| Sep 30, 2025 | 47.13 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | -135,000.00 |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -68.19 Mn |
| Mar 31, 2023 | 29.87 Mn |
| Dec 31, 2022 | 38.16 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | -10.11 Mn |
| Sep 30, 2021 | 9.58 Mn |
| Jun 30, 2021 | -283,000.00 |
| Mar 31, 2021 | -8.05 Mn |
| Dec 31, 2020 | 8.16 Mn |
| Sep 30, 2020 | -20.85 Mn |
API Access
Arrowhead Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();